Corporate Events
Board MeetingABCL
20265Aug
Board Meeting
Q2 2026 Earnings Conference Call — AbCellera Biologics Inc. …
SEC Filing ↗ Board MeetingABCL
202630Jun
Board Meeting
Appointment of Lynn Seely, M.D. as a new Class III independe…
SEC Filing ↗ Board MeetingABCL
202611Jun
Board Meeting
Annual Meeting of Shareholders to elect two Class III direct…
SEC Filing ↗ Board MeetingABCL
20261Jun
Board Meeting
Appointment of Victor Sandor as an independent director to t…
SEC Filing ↗ Board MeetingABCL
202611May
Board Meeting
AbCellera Biologics Inc. reported its Q1 2026 financial resu…
SEC Filing ↗